Lung cancer is categorized into stages based on the size of the tumor, its spread to nearby tissues or lymph nodes, and whether it has metastasized to other parts of the body. Understanding these stages is crucial for determining the most appropriate treatment plan.
| Stage | Description | Subcategories |
|---|---|---|
| Stage 0 | Carcinoma in Situ: The cancer is localized to the innermost lining of the lung, small, and has not spread. | - |
| Stage I | Localized Cancer: The cancer is limited to the lung, no spread to lymph nodes. | Stage IA: Tumor ≤ 3 cm; Stage IB: Tumor > 3 cm but ≤ 4 cm, or involves nearby lung structures. |
| Stage II | Larger or Locally Spread Cancer: The tumor may be up to 5 cm or spread to nearby lymph nodes. | Stage IIA: Tumor ≤ 5 cm, no lymph node involvement; Stage IIB: Tumor 5–7 cm or involves local lymph nodes. |
| Stage III | Locally Advanced Cancer: Cancer has spread to nearby lymph nodes or structures within the chest. | Stage IIIA: Spread to lymph nodes on the same side of the chest; Stage IIIB: Spread to lymph nodes on the opposite side or other structures. |
| Stage IV | Metastatic Cancer: The cancer has spread to distant organs such as the brain, liver, bones, or the other lung. | Stage IVA: Limited spread to the same lung or nearby fluid (e.g., pleural effusion); Stage IVB: Widespread metastasis to multiple distant organs. |
Early-stage lung cancer often has no symptoms, but as the disease progresses, the following signs may appear
| Stage | Symptoms | Description |
|---|---|---|
| Early-Stage Symptoms | Persistent cough | Chronic or worsening cough that doesn’t go away. |
| Coughing up blood (hemoptysis) | Even small amounts of blood in sputum can be a warning sign. | |
| Shortness of breath | Difficulty breathing or a feeling of tightness in the chest. | |
| Wheezing | A whistling or high-pitched sound when breathing. | |
| Chest pain | Pain or discomfort, especially during deep breathing, coughing, or laughing. | |
| Fatigue | Persistent tiredness or a lack of energy. | |
| Unexplained weight loss | Losing weight without dieting or increased physical activity. | |
| Loss of appetite | Reduced interest in eating. | |
| Fever | Low-grade fever, sometimes with no obvious infection. | |
| Advanced-Stage Symptoms | Bone pain | Often in the back or hips, indicating cancer spread. |
| Swelling in the face or neck | Caused by a tumor pressing on blood vessels. | |
| Hoarseness | A raspy voice caused by pressure on nerves controlling the vocal cords. | |
| Neurological symptoms | Headaches, dizziness, or seizures if the cancer has spread to the brain. | |
| Jaundice | Yellowing of the skin and eyes, which may occur if the liver is affected. |
Lung cancer arises due to a combination of genetic, environmental, and lifestyle factors. Here’s a breakdown of the primary causes and risk factors:
| Category | Risk factor | Description |
|---|---|---|
| Smoking and Exposure | Smoking and Secondhand Smoke | Smoking causes about 85% of lung cancer cases; secondhand smoke also significantly raises risk. |
| Environmental Factors | Carcinogens and Environmental Exposure | Long-term exposure to radon gas, asbestos, arsenic, and air pollution increases risk, particularly common in industrial settings or urban areas. |
| Genetic Factors | Genetic Predisposition | Family history and inherited mutations (e.g., EGFR gene) heighten risk, even among non-smokers. |
| Health Conditions | Chronic Lung Diseases | Conditions like COPD or pulmonary fibrosis make lungs more vulnerable to cancer. |
| Prior Treatments | Prior chest radiation therapy increases susceptibility. | |
| Demographics | Age | Lung cancer is more prevalent in individuals over 65. |
| Gender | Non-smoking women may face a higher risk due to hormonal or genetic factors. | |
| Lifestyle Choices | Poor Diet | A poor diet can weaken the immune system, indirectly increasing risk. |
| Lack of Exercise | Limited physical activity reduces overall health and resilience. | |
| Heavy Alcohol Consumption | Excessive alcohol use can contribute to weakened immunity and higher susceptibility. |
Diagnosing lung cancer typically involves a combination of medical history reviews, physical exams, imaging studies, laboratory tests, and biopsies. The process begins with the evaluation of symptoms and risk factors, such as smoking history or exposure to environmental carcinogens.
| Method | Purpose | When it is used |
|---|---|---|
| Chest X-ray | Provides an initial evaluation of potential lung abnormalities. | When symptoms like persistent cough, chest pain, or shortness of breath are present. |
| CT Scan (Computed Tomography) | Confirms findings from chest X-rays and offers more precise visualization of abnormalities. | When an X-ray suggests abnormalities or detailed imaging is required for diagnosis or staging. |
| PET Scan (Positron Emission Tomography) | Determines the extent and spread of cancer for staging purposes. | When cancer has been confirmed, and staging or identifying metastasis is required. |
| Sputum Cytology | Detects cancers in central parts of the lungs. | When a patient produces sputum, especially with blood, or when central lung tumors are suspected. |
| Bronchoscopy | Helps diagnose central lung tumors and gather tissue samples. | When imaging shows central lung abnormalities or tumors requiring biopsy or direct visualization. |
| Needle Biopsy | Confirms cancer in tumors near the chest wall or deeper in the lungs. | When tumors are located in deep lung tissue or near the chest wall and require sampling for analysis. |
| Thoracentesis | Checks for cancer cells in pleural fluid. | When there is fluid accumulation around the lungs, causing symptoms like shortness of breath. |
| Mediastinoscopy | Determines if cancer has spread to chest lymph nodes. | When lymph node involvement is suspected, especially for staging or treatment planning. |
| Molecular Testing | Guides personalized treatment plans based on identified mutations. | When cancer is confirmed, to tailor treatment strategies like targeted or immunotherapy. |
| Blood Tests | May indicate the presence of cancer and help assess general health status. | When general health assessment is needed or tumor marker levels could aid in monitoring cancer. |
The survival rate for lung cancer depends on various factors, including the type of lung cancer, the stage at diagnosis, the patient's overall health, and the treatments available. Generally, the survival rates are expressed as the 5-year relative survival rate, which indicates the percentage of people who are still alive five years after their diagnosis compared to those without the disease.
| Type Of Cancer | Stage | Survival Rate |
|---|---|---|
| Non-Small Cell Lung Cancer (NSCLC) | Localized (early stage, confined to the lung) | 63% |
| Regional (spread to nearby lymph nodes or structures) | 35% | |
| Distant (metastatic, spread to other parts of the body) | 7% | |
| Small Cell Lung Cancer (SCLC) | Limited stage (confined to one lung and nearby lymph nodes) | 27% |
| Extensive stage (spread to other parts of the body) | 3% |
| Type Of Cancer | Subtype | Treatment Options |
|---|---|---|
| Non-Small Cell Lung Cancer (NSCLC) | Adenocarcinoma / Adenosquamous Carcinoma |
Early Stage (I/II): Surgical resection + Adjuvant chemotherapy (if high risk of recurrence). Radiation therapy (RT) for inoperable tumors. Locally Advanced (III): Chemotherapy (CT) + RT (with or without surgery), Immunotherapy, Targeted therapy (if EGFR, ALK mutations are present). Advanced Stage (IV): Targeted therapy (if EGFR, ALK, ROS1 mutations are present), Immunotherapy, Chemotherapy (palliative care). |
| Squamous Cell Carcinoma |
Early Stage (I/II): Surgery (preferred option). Radiation therapy (RT) for inoperable tumors or if surgery is not viable. Locally Advanced (III): Chemotherapy + RT (typically), Surgery + adjuvant chemotherapy. Advanced Stage (IV): Chemotherapy + Immunotherapy (standard treatment). |
|
| Large Cell (Undifferentiated) Carcinoma |
Early Stage (I/II): Surgery (preferred option). Radiation therapy (RT) for inoperable tumors or if surgery is not viable. Advanced Stage (III/IV): Chemotherapy, Chemotherapy + Immunotherapy, Targeted therapy (if EGFR, ALK mutations are present). |
|
| Small Cell Lung Cancer (SCLC) | Oat Cell Cancer (Classic SCLC) |
Limited Stage: Chemotherapy (platinum-based) + RT (standard) + Prophylactic Cranial Irradiation (PCI). Locally Advanced (III): Chemotherapy (primary treatment). Chemotherapy + Immunotherapy (often used). PCI if the patient responds well to initial treatment. |
| Lung Carcinoid Tumors | Typical Carcinoids |
Surgery (primary treatment option). Radiation therapy + Somatostatin analogs (to control hormone-related symptoms). |
Here are the common side effects of lung cancer treatment:
Our administration and support staff all have exceptional people skills and trained to assist you with all medical enquiries.
Our administration and support staff all have exceptional people skills and trained to assist you with all medical enquiries.
To reduce patient discomfort, we are strategically located all across Telangana, minimizing commute times for our patients.
Our Most Experienced Oncologists provide you with all viable treatment options, including associated risks, while maintaining transparency.
We offer the lowest costs for all Treatments (Surgery, Chemotherapy, Radiation) and Diagnostics (PET CT, Biopsy) compared to others.
What are the common symptoms of lung cancer?
+What are the treatment options available for lung cancer in Hyderabad?
+How is lung cancer diagnosed?
+Can lung cancer be treated without surgery?
+What is IGRT, and how does it help in lung cancer treatment?
+How long does lung cancer treatment take?
+Is smoking cessation a part of lung cancer treatment?
+What are the side effects of lung cancer treatments?
+